Skip to main content
logo
Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.130
+0.220 (24.18%)
At close: May 13, 2026, 4:00 PM EDT
1.110
-0.020 (-1.77%)
Pre-market: May 14, 2026, 5:48 AM EDT

Humacyte Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.022.04--1.571.26
Revenue Growth (YoY)
289.94%---23.91%-15.29%
Cost of Revenue
11.599.7----
Gross Profit
-9.58-7.66--1.571.26
Selling, General & Admin
30.9731.1725.823.522.8821.13
Research & Development
73.3569.388.676.5563.2661.34
Total Operating Expenses
104.31100.47114.4100.0586.1482.47
Operating Income
-113.89-108.14-114.4-100.05-84.58-81.21
Interest Income
2.262.594.15.472.630.02
Interest Expense
-10.52-11.25-9.28-6.6-6.2-4.35
Other Non-Operating Income (Expense)
46.8375.97-29.13-9.677.7560.33
Total Non-Operating Income (Expense)
38.5667.3-34.3-10.7374.1855.99
Pretax Income
-75.32-40.83-148.7-110.78-10.4-25.21
Net Income
-75.32-40.83-148.7-110.78-10.4-25.21
Net Income to Common
-75.32-40.83-148.7-110.78-10.4-25.21
Shares Outstanding (Basic)
17515811810310340
Shares Outstanding (Diluted)
17515811810310340
Shares Change (YoY)
40.43%33.49%14.56%0.36%157.82%-
EPS (Basic)
-0.57-0.26-1.26-1.07-0.12-0.66
EPS (Diluted)
-0.57-0.26-1.26-1.07-0.12-0.66
Shares Outstanding
222.02193130.03103.67103.23103
Free Cash Flow
-102.38-105.93-99.69-75.59-72.18-81.41
Free Cash Flow Per Share
-0.59-0.67-0.84-0.73-0.70-2.04
Gross Margin
-475.05%-376.06%--100.00%100.00%
Operating Margin
-5649.21%-5306.04%---5404.35%-6429.77%
Profit Margin
-3736.31%-2003.58%---664.54%-1996.36%
FCF Margin
-5078.17%-5197.55%---4611.95%-6445.76%
EBITDA
-106.59-100.79-107.21-92.33-76.37-72.97
EBITDA Margin
-5286.95%-4945.63%---4879.74%-5777.28%
EBIT
-113.89-108.14-114.4-100.05-84.58-81.21
EBIT Margin
-5649.21%-5306.04%---5404.35%-6429.77%
Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q